Brooke D. Paradise

510 total citations
9 papers, 360 citations indexed

About

Brooke D. Paradise is a scholar working on Molecular Biology, Oncology and Pharmacy. According to data from OpenAlex, Brooke D. Paradise has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Pharmacy. Recurrent topics in Brooke D. Paradise's work include Hedgehog Signaling Pathway Studies (4 papers), Epigenetics and DNA Methylation (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Brooke D. Paradise is often cited by papers focused on Hedgehog Signaling Pathway Studies (4 papers), Epigenetics and DNA Methylation (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Brooke D. Paradise collaborates with scholars based in United States, Italy and Switzerland. Brooke D. Paradise's co-authors include Martín E. Fernández-Zapico, Ashley N. Sigafoos, Wen Wee, Hao Xie, Whitney Barham, Barbara Stecca, Fabrizio Manetti, Silvia Pietrobono, Luciana L. Almada and Jann N. Sarkaria and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Cancer Research.

In The Last Decade

Brooke D. Paradise

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brooke D. Paradise United States 7 290 92 51 45 43 9 360
Hakki Ogün Sercan Türkiye 10 259 0.9× 97 1.1× 55 1.1× 24 0.5× 35 0.8× 22 364
Zhaodi Gu Japan 10 338 1.2× 103 1.1× 86 1.7× 39 0.9× 44 1.0× 18 395
Karen Gambaro Canada 11 266 0.9× 114 1.2× 65 1.3× 19 0.4× 33 0.8× 18 384
Laurie Herviou France 11 344 1.2× 71 0.8× 45 0.9× 73 1.6× 45 1.0× 20 452
B. Florien Westendorp Netherlands 8 214 0.7× 125 1.4× 54 1.1× 99 2.2× 44 1.0× 9 343
Jessica Kalra Canada 11 270 0.9× 88 1.0× 71 1.4× 35 0.8× 23 0.5× 16 404
Kasia Weina Germany 7 293 1.0× 127 1.4× 88 1.7× 27 0.6× 19 0.4× 7 391
Frauke Nitzki Germany 11 361 1.2× 77 0.8× 36 0.7× 50 1.1× 76 1.8× 16 453
Hisataka Kitano Japan 10 149 0.5× 60 0.7× 56 1.1× 45 1.0× 50 1.2× 37 274
Lucia Gullotti Germany 6 417 1.4× 85 0.9× 56 1.1× 55 1.2× 47 1.1× 9 533

Countries citing papers authored by Brooke D. Paradise

Since Specialization
Citations

This map shows the geographic impact of Brooke D. Paradise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke D. Paradise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke D. Paradise more than expected).

Fields of papers citing papers by Brooke D. Paradise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke D. Paradise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke D. Paradise. The network helps show where Brooke D. Paradise may publish in the future.

Co-authorship network of co-authors of Brooke D. Paradise

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke D. Paradise. A scholar is included among the top collaborators of Brooke D. Paradise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke D. Paradise. Brooke D. Paradise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Paradise, Brooke D., Vladimir G. Gainullin, Luciana L. Almada, et al.. (2023). SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. Biochemical Journal. 480(15). 1199–1216. 4 indexed citations
2.
Peterson, Timothy E., Raman Deep Singh, Ao Shi, et al.. (2022). Exosome biopotentiated hydrogel restores damaged skeletal muscle in a porcine model of stress urinary incontinence. npj Regenerative Medicine. 7(1). 58–58. 25 indexed citations
3.
Pietrobono, Silvia, Eugenio Gaudio, Sinforosa Gagliardi, et al.. (2021). Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma. Oncogene. 40(22). 3799–3814. 32 indexed citations
4.
Sigafoos, Ashley N., Brooke D. Paradise, & Martín E. Fernández-Zapico. (2021). Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease. Cancers. 13(14). 3410–3410. 142 indexed citations
5.
McCleary‐Wheeler, Angela L., Brooke D. Paradise, Luciana L. Almada, et al.. (2020). TFII-I-mediated polymerase pausing antagonizes GLI2 induction by TGFβ. Nucleic Acids Research. 48(13). 7169–7181. 7 indexed citations
6.
Pietrobono, Silvia, Fabrizio Manetti, Luciana L. Almada, et al.. (2020). ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nature Communications. 11(1). 5865–5865. 66 indexed citations
7.
Xie, Hao, Brooke D. Paradise, Wen Wee, & Martín E. Fernández-Zapico. (2019). Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer. Cells. 8(5). 394–394. 60 indexed citations
8.
Paradise, Brooke D., Whitney Barham, & Martín E. Fernández-Zapico. (2018). Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?. Cancers. 10(5). 128–128. 23 indexed citations
9.
Mathison, Angela, et al.. (2017). Abstract 1391: The epigenetic regulator, G9a, is a KRAS-inducible protein and its inactivation inhibits PanIN formation by this oncogene. Cancer Research. 77(13_Supplement). 1391–1391. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026